Elevation Oncology
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Elevation Oncology generated cash of -$56,180,000, which is more than the previous year. Cash used in financing activities reached the amount of $47,975,000 last year. Net change in cash is therefore $3,338,000.
Cash Flow
| 2019 | -5.45M | 0 | 7.19M |
|---|---|---|---|
| 2020 | -12.29M | -71K | 90.02M |
| 2021 | -30.16M | 0 | 97.05M |
| 2022 | -85.48M | -44.39M | 29.51M |
| 2023 | -56.18M | 11.54M | 47.97M |
ELEV Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 45.91M | 146.28M | 79.4M | 1.74M | 0 |
Operating activities | |||||
Net income | -45.70M | -95.08M | -32.03M | -17.26M | -5.88M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 39K | 27K | 18K | 15K | 0 |
Stock-based compensation expense | 3.33M | 3.20M | 1.57M | 52K | 13.5K |
| Deferred income tax benefit | 3.33M | 3.20M | 1.57M | 52K | 13.5K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -5.85M | 711K | -30K | 5.21M | 460K |
Cash generated by operating activities | -56.18M | -85.48M | -30.16M | -12.29M | -5.45M |
Investing activities | |||||
Purchases Of Investments | -42.65M | -112.31M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -86K | 0 | -71K | 0 |
Acquisitions Net | 0 | 44.31K | 0 | 0 | 0 |
Cash generated by investing activities | 11.54M | -44.39M | 0 | -71K | 0 |
Financing activities | |||||
Common Stock Issued | 46.50M | 0 | 97.06M | 20K | 7.19M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -24K | -35K | 0 | 0 | 0 |
Repayments of term debt | 0 | 30M | 0 | 0 | 0 |
Cash used in financing activities | 47.97M | 29.51M | 97.05M | 90.02M | 7.19M |
Net Change In Cash | 3.33M | -100.36M | 66.88M | 77.66M | 1.74M |
Cash at end of period | 49.25M | 45.91M | 146.28M | 79.4M | 1.74M |
| Data source | Data source | Data source |